SMOC2 and endometrial cancer: A recent study identified SPARC-related modular calcium-binding 2 (SMOC–2) as a novel endometrial cancer stem cell signature gene and demonstrated that SMOC-2 is involved in activation of the Wnt/β-catenin pathway [185].